Patents by Inventor Milton G. Mutchnick

Milton G. Mutchnick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the treatment of hepatitis
    Patent number: 6106868
    Abstract: A method for the treatment of viral induced hepatitis B in mammals, particularly humans, by injecting a thymosin is described. The method is particularly effective in the treatment of chronic hepatitis B using bovine calf thymosin fraction 5 which contains thymosin alpha.sub.1 or bovine calf or synthetic thymosin alpha.sub.1.
    Type: Grant
    Filed: August 24, 1990
    Date of Patent: August 22, 2000
    Assignee: The Board of Governors of Wayne State University
    Inventor: Milton G. Mutchnick
  • Method and composition for treatment of patients having decompensated liver disease
    Patent number: 5750501
    Abstract: A method and composition for treating a Hepatitis B patient having hepatic decompensation utilizes Hepatitis B virus-reducing amounts of T.alpha..sub.1, administered to a patient having decompensated liver disease so as to render the patient seronegative for Hepatitis B virus DNA.
    Type: Grant
    Filed: September 26, 1996
    Date of Patent: May 12, 1998
    Assignees: Alpha 1 Biomedicals, Inc., The Board of Governors of Wayne State Univ.
    Inventors: Paul B. Chretien, Milton G. Mutchnick
  • Method for treatment of autoimmune hepatitis
    Patent number: 5468729
    Abstract: A method and composition for treating autoimmune hepatitis in a patient utilizes an immunomodulatory amount of T.alpha..sub.1 and an anti-inflammatory amount of a corticosteroid.
    Type: Grant
    Filed: October 26, 1993
    Date of Patent: November 21, 1995
    Assignees: Alpha 1 Biomedicals, The Board of Governers of Wayne State University
    Inventors: Paul B. Chretien, Milton G. Mutchnick
  • Method and kit for assay for measurement of serum thymosin alpha.sub.1
    Patent number: 4950590
    Abstract: A micro-enzyme described immunosorbent assay (microELISA) method is described for detecting small amounts of thymosin alpha.sub.1 in a solution such as serum. The method uses a known amount of an antibody to the thymosin alpha.sub.1 which is reacted with the thymosin alpha.sub.1 in solution to form a first complex. The solution with the first complex and unreacted antibody is then contacted with thymosin alpha.sub.1 bound to a solid phase which quantitatively forms a second complex with the unreacted antibody. The amount of the second complex is determined and correlated with the amount of thymosin alpha.sub.1 of the solution. Thymosin alpha.sub.1 is an important hormone the presence or absence of which is significant clinically.
    Type: Grant
    Filed: January 13, 1986
    Date of Patent: August 21, 1990
    Assignee: Board of Governors of Wayne State University
    Inventors: Milton G. Mutchnick, Frederick E. Weller